LDU Resources for Testing Personnel Qualifications in Moderate and High Complexity Laboratories

CDC
258 followers
Jul 16, 2026
This webinar focuses on the qualification requirements for personnel performing moderate and high complexity laboratory testing. The video provides a clear overview of regulatory expectations, competency standards, and best practices to ensure compliance with the Clinical Laboratory Improvement Amendments (CLIA) regulations.
AI Generated·May contain errors
So it's three minutes after. We want to make sure that we're taking care of your time. So again,
good morning and thank you all for being here. My name is Tamera McMillan and I am a consultant
with GuideHouse supporting the CDC's OneLab initiative. A couple notes about the webinar
before we dive in. If you're having any technical difficulties throughout, feel free to email the
OneLab inbox for support. That's one lab at cdc.gov. If you have any questions throughout
the session, insert them in the Q&A function below and we'll make sure that we get to them
during the Q&A session. Now again, given the number of persons that are here, please know
that we might not be able to get to every one of your questions here, but we will definitely make
sure you get an answer. Additionally, note that the post for those that are needing live caption
has also been dropped in the chat. So please be sure to keep both the caption window open if you
need and also the Teams webinar. Next, we're going to look at our agenda. So today, we will start by
discussing new OneLab resources. Then we will go through some introductions. We'll have about a 10
minute Q&A again session at the end, where you have an opportunity to sit at the feet of our
dynamic presenter. We'll review the questions and do our best again to answer them. And today's
session, we will then discuss upcoming networking events. So now, about the webinar, we will be
leaving the chat feature open for your engagement. When utilizing the chat box, please keep in mind
the appropriate rules of engagement. Feel free to use the chat to connect with one another, react
to one another, what you're hearing and sharing experiences, and asking questions of your fellow
participants. If you have a question for the presenter, again, please use the Q&A function,
not the chat. Additionally, please engage in respectful and professionalism. We are into
inappropriate language, improper conduct, or any form of discrimination may result in removal from
the webinar. Please ensure your comments are relevant to the topic. And if the moderator gives
direction regarding chat behavior, please comply accordingly. Lastly, please notify the moderators
if you're experiencing any technical difficulties, or observe any disruptive behavior. I'll now turn
it over to our OneLab Network lead, Alicia Branch, to share some of our new and relevant resources.
Thank you, Alicia. Thank you, Tamera. Like Tamera said, before we begin the main presentation,
I'm happy to announce that the updated version of Ready, Set, Test, patient testing is important,
get the right result, e-learning course is live on OneLab Reach, and available on the
Laboratory Director University page with CME and CEU options. This basic level training helps
to ensure that testing personnel have the training necessary to safely and accurately perform
clear way patient testing. The link to the updated course has been placed in the chat.
Next slide, please. Now, I'll read two disclaimers. The first one is our PACE disclaimer,
followed by the external presenter disclaimer. And then I'll introduce our speaker for today.
Subject matter experts and presenter wish to disclose they have no conflict of interest
or other relationship with the manufacturers of commercial products, the supply of commercial
services, commercial supporters, or other organizations related to the course. Next
slide, please. Slide decks may contain presentation material for panelists who are not affiliated
with CDC. Presentation content from external panelists may not necessarily reflect CDC's
official position on the topics covered. And next slide, please. I'm excited to introduce
our presenter today, Ms. Cheryl Dowie. Cheryl is a technical advisor in the Division of Clinical
Laboratory Improvement and Quality at the Center for Medicare and Medicaid Services.
She has over 30 years of experience as a clinical laboratory scientist,
and she has been a part of the CLEAR program at CMS for more than 14 years. Cheryl has been
dedicated to developing Laboratory Director University and is excited to promote the new
personnel courses. Over to you, Cheryl. Good morning and good afternoon, everyone.
And good evening. I saw some chats popping up for folks outside of the U.S., so welcome.
Today, we're going to focus on why CLEA-certified laboratories require qualified personnel and how
that safeguards patient care. We are introducing two new Laboratory Director University, or LDU,
as we like to call it, courses that address personnel qualifications and responsibilities
for moderate and high-complexity testing. In these clinical laboratories,
testing can be technically demanding and results directly affect clinical decisions.
Qualified personnel are foundational to reliable testing, regulatory compliance,
and patient safety. The new LDU courses help laboratory leaders understand and implement
these requirements effectively. Next slide, please.
The Centers for Medicare and Medicaid Services, Division of Clinical Laboratory Improvement and
Quality, or CMS DCLIC, have partnered with the Centers for Disease Control and Prevention,
Division of Laboratory Systems, or CDC DLS, to develop a comprehensive program aimed to assist
laboratories with their compliance to the Clinical Laboratory Improvement Amendments,
or CLEA, regulations, enhancing the quality and reliability of clinical laboratory testing
across the nation. Next slide, please. By the end of today's session, you will be able to identify
the CLEA-required personnel positions involved in clinical laboratory testing for laboratories that
perform moderate and high-complexity testing and summarize the purpose and scope of the personnel
qualifications and responsibilities moderate-complexity testing and personnel
qualifications and responsibility high-complexity testing courses. During this webinar, we will
address only those questions that pertain to the events topics. For all other inquiries,
please contact CMS Laboratory Excellence at labexcellence at cms.hhs.gov. And there will be
a slide at the end with the CMS contact information in case you didn't catch that email address,
and I believe we also just dropped it in the chat. Next slide, please.
CMS DCLIC and the CDC DLS have partnered to create Laboratory Director University,
focusing on the critical need for training and education among laboratory directors who
are responsible for CLEA requirements. With self-paced learning, LDU's flexible environment
offers high-quality education resources that help CLEA laboratory directors who are responsible
for the overall operations, administration, and compliance in CLEA-certified laboratories.
LDU offers free, focused e-learning for laboratory directors who oversee CLEA-certified laboratories
with continuing medical education or CME credits for each course. Next slide, please.
So, LDU focuses on improvements in documentation, quality control, and quality assurance,
CLEA proficiency testing, unsatisfactory results and unsuccessful performance in PT,
and evaluation of testing systems. These components support continuous quality
improvement across non-wave testing. Next slide, please.
Under CLEA, laboratory testing must meet accuracy, reliability, and timeliness standards.
CMS, the CDC, and the FDA each have a unique role in ensuring laboratory quality testing
under CLEA regulations. Laboratory Director University now includes two key courses,
one for moderate-complexity personnel and one for high-complexity personnel. These are designed
to help staff better understand the personnel requirements under CLEA. Next slide, please.
As a reminder, any laboratory performing testing on human-derived specimens for the diagnosis,
prevention, or treatment of disease must be CLEA-certified. Tests fall into two categories,
waved and non-waved, based on complexity. Non-waved tests must meet more rigorous
quality system standards. Non-waved clinical laboratory test systems are assigned a moderate
or high-complexity category by the FDA based on seven criteria given in the CLEA 88 regulations.
Next slide, please. Moderate-complexity tests require more technical skill than waved tests
but are less complex than high-complexity tests. Examples include rapid antigen tests,
certain immunoassays, and some microscopy procedures. Understanding these differences
affects laboratory staffing, training, and compliance obligations. Next slide, please.
High-complexity tests require advanced scientific knowledge, specialized equipment,
and extensive training. Examples include molecular diagnostics, cytogenetics, flow cytometry,
and immunohematology for transfusion. Because of their complexity, they present a greater risk
of error if not performed correctly, and laboratory personnel must meet rigorous qualifications.
Next slide, please. Both moderate-complexity and high-complexity testing require each person
filling a CLEA-required position must meet the qualifications for that position. Depending on
the position, different combinations of education, training, and or experience may satisfy CLEA
qualification requirements. Training or experience must be obtained in a CLEA-certified laboratory.
And the standards for moderate and high-complexity testing differ only in personnel requirements.
Understanding these differences between moderate and high-complexity testing is crucial for
laboratory operations. Laboratories must ensure that they have the appropriate resources and
personnel to perform tests accurately, reliably, and timely. Next slide, please. So, this slide
outlines the required positions for moderate and high-complexity testing. For moderate-complexity,
required positions include the laboratory director, technical consultant, clinical consultant,
and testing personnel. For high-complexity, in addition to the laboratory director and testing
personnel, additional supervisory roles are required, including the technical supervisor
and general supervisor. And for the subspecialty of cytology, the laboratory must have a cytology
technical supervisor and cytology general supervisor who provides supervision, as well as
a sufficient number of cytotechnologists to perform the cytology functions of the laboratory.
Next slide, please. The moderate-complexity and high-complexity testing courses each explain the
required personnel qualifications and training of personnel based on the type of testing performed
in the laboratory. The courses are designed for individuals who are involved in moderate
and high-complexity testing across various specialties and subspecialties. Each course
includes progressive scenarios that introduce personnel engaged in moderate and high-complexity
testing in a CLIA-certified laboratory. Next slide, please. On this slide, we begin looking
closely at the CLIA-required personnel roles for moderate-complexity testing. Under CLIA Subpart
M, each of these roles carries specific qualifications and responsibilities that
ensure laboratories maintain accurate, reliable, and timely patient testing.
So, let's walk through each role at a high level. The laboratory director holds ultimate
responsibility for the overall operation and administration of the moderate-complexity
laboratory. This includes ensuring that the lab is staffed with qualified and competent personnel,
that test procedures are performed correctly, and that results are reported promptly and accurately.
The director maintains oversight of compliance with CLIA regulations, quality systems,
and ongoing training. They are accountable for the accuracy, reliability, and timeliness of all
testing performed under their CLIA certificate. The technical consultant brings subject matter
expertise in each specialty or subspecialty where the laboratory performs moderate-complexity
testing. This role provides technical and scientific oversight, advises on test selection,
ensures accurate test performance, and helps troubleshoot testing issues. They must be
accessible to staff and are critical in guiding the lab's technical quality. The clinical
consultant supports the appropriate use and interpretation of laboratory tests. This
individual consults with healthcare providers on test selection, clinical relevance, and
interpretation of results. Their role helps bridge the gap between laboratory data and patient care
decisions. And finally, testing personnel. They carry out the hands-on work, test performance,
quality control checks, and accurate result reporting. They must meet the CLIA qualifications
for moderate-complexity testing and follow all quality standards. Their competency is essential,
and laboratories must ensure training and competency assessment are performed regularly.
As outlined in the LDU materials, understanding these roles and how they interconnect
is key to maintaining compliance and high-quality testing in a moderate-complexity environment.
Next slide, please. So here's our first poll. Which position is required in a moderate-complexity
laboratory? We'll give you all a little bit of time. Please respond to the poll, and then we'll
go over the correct answer. All right. It looks like we've got a lot of answers. So the correct
answer is technical consultant. The technical consultant brings subject matter expertise
in each specialty or subspecialty where the laboratory performs moderate-complexity testing.
This role provides technical and scientific oversight, advises on test selection,
ensures accurate test performance, and helps troubleshoot testing issues.
They must be accessible to staff and are critical in guiding the lab's technical quality.
Next slide, please. The CLIA personnel qualifications and responsibilities
moderate-complexity testing e-learning course is intended for clinical laboratory staff
and others who are involved in CLIA non-waved moderate-complexity testing across various
specialties and subspecialties and those working with tests that the FDA has not classified
into a specific specialty or subspecialty. The course provides a brief overview of the
requirements, duties, and credentials of personnel who perform or oversee moderate-complexity testing
subject to the CLIA regulations. One hour of CME credit is available for this course.
Next slide, please. Now we shift to the roles required in high-complexity testing,
which under CLIA subpart M include additional supervisory roles due to the greater level of risk
and the sophistication of the testing involved. As our curriculum highlights, these personnel
ensure testing meets the strict accuracy and reliability standards required for non-waved
high-complexity assays. So here's a high-level look at the first set of required roles.
The laboratory director holds ultimate responsibility for the overall operation
and administration of the high-complexity laboratory. This includes ensuring the lab
is staffed with qualified and competent personnel, that test procedures are performed correctly,
and that results are reported promptly and accurately. The lab director maintains
oversight of compliance with CLIA regulations, quality systems, and ongoing training. They are
accountable for the accuracy, reliability, and timeliness of all testing performed under their
CLIA certificate. The technical supervisor provides high-level, provides expert-level
oversight within each specialty and subspecialty of high-complexity testing. They are responsible
for the technical and scientific oversight of high-complexity testing, for evaluating new test
methods, ensuring proper performance verification, monitoring quality control, and resolving
technical problems. The clinical consultant supports the appropriate use and interpretation
of laboratory tests. This individual consults with healthcare providers on test selection,
clinical relevance, and interpretation of results. Their role helps bridge the gap between
laboratory data and patient care decisions. The general supervisor oversees the day-to-day
operations of testing personnel engaged in high-complexity testing. This includes monitoring
test performance, reviewing quality control, ensuring adherence to procedures, and verifying
the accuracy of reported results. They provide direct oversight to ensure routine testing meets
all CLIA requirements. They must be accessible to staff and are critical in guiding the lab's
technical quality. These roles form the leadership and oversight structure that upholds compliance
and quality in high-complexity laboratories. Next slide, please. Testing personnel in high-complexity
labs must meet elevated education and training requirements. Testing personnel carry out the
hands-on work, test performance, quality control checks, and accurate result reporting. They must
meet the CLIA qualifications for high-complexity testing and follow all quality standards.
Their competency is essential, and laboratories must ensure training and competency assessment
are performed regularly. And CLIA Subpart M identifies three additional personnel categories
specific for cytology, which requires unique training and education. Again, these roles exist
to ensure accurate and reliable testing, a principle highlighted throughout the CLIA personnel
courses. The cytology technical supervisor oversees the technical performance of cytology testing.
Responsibilities include verifying workload limits for cytotechnologists, ensuring compliance
with proficiency testing, confirming interpretation accuracy for gynecologic specimens, and maintaining
quality control systems specific to cytology. The cytology general supervisor provides day-to-day
oversight of cytology testing operations. Responsibilities include verifying slide
interpretation documentation, tracking the number of slides examined, and ensuring
cytotechnologists or cytology testing personnel remain within workload limits and competency
expectations. They must meet stringent qualifications, often including state licensure
and specialty training. And finally, cytotechnologists perform the microscopic
evaluation of gynecologic and non-gynecologic specimens. They document interpretations,
track hours and slide counts, and maintain strict adherence to quality assurance requirements.
Their expertise is foundational to accurate cytology diagnosis and patient care. Together,
these roles comprise the specialized cytology workforce required under CLIA for high-complexity
testing. They ensure that each step from slide preparation to interpretation is performed by
qualified personnel capable of meeting strict federal standards. Next slide, please. So, we
have another poll for you. Do you know which of these positions are required in a CLIA laboratory
that performs high-complexity testing? Please select your answer to the poll, and then we'll
go over the correct responses. All right. It looks like we have a lot of responses. So, the two
positions on this list that are required for high-complexity testing are technical supervisor,
who provides expert-level oversight within each specialty and subspecialty of high-complexity
testing. The technical supervisor is responsible for the technical and scientific oversight of
high-complexity testing, evaluating new test methods, ensuring proper performance verification,
monitoring quality control, and resolving technical problems. The second role on this list
that is correct is the general supervisor, who oversees the day-to-day operations of testing
personnel engaged in high-complexity testing. This includes monitoring test performance,
reviewing quality control, ensuring adherence to procedures, and verifying the accuracy of
reported results. They provide direct oversight to ensure routine testing meets all CLIA requirements.
They must be accessible to staff and are critical in guiding the lab's technical quality.
These roles form the leadership and oversight structure that upholds compliance and quality
in high-complexity laboratories. Next slide, please. We are excited to introduce a Laboratory
Director University Cornerstone course, CLIA Personnel Qualifications and Responsibility
High-Complexity Testing. This course will provide an overview of the qualifications and
responsibilities of laboratory personnel who perform or oversee high-complexity testing subject
to CLIA regulations. It is designed for clinical laboratory staff and others involved in CLIA
non-waved high-complexity testing across various specialties and subspecialties and those working
with tests that the Food and Drug Administration has not classified into a specialty or subspecialty.
And this course is approved for one CME or continuing medical education credit.
And if you're new to OneLab Reach, please create a free account to access relevant education and
training resources, earn continuing education units, and download materials. Next slide, please.
As part of the LDU Personnel Course Job Aids, we have developed a series of personnel qualification
checklists. These checklists provide a brief overview of the education and training credentials
required for personnel who perform non-waved testing under CLIA. These checklists will provide
guidance for laboratory directors and managers looking to fill positions with qualified candidates
or for laboratory personnel looking to track their pathways to qualify for CLIA-required positions
for moderate and high-complexity testing. Each checklist will provide all the qualification
pathways for each personnel role. Next slide, please. Here is an example of the checklist
for qualifying an individual as a testing personnel performing moderate-complexity testing.
Mr. Green is reviewing Ms. Smith's qualifications to determine suitability for testing personnel
in a CLIA-certified laboratory performing moderate-complexity testing. Ms. Smith has
an associate's degree in medical laboratory technology. As you can see on the checklist,
this qualifies her for Pathway 9, which is aligned to the CLIA regulations at 42 CFR,
Part 493.1423B4. Next slide, please. As you can see, each checklist provides all the pathways
through which an individual can qualify for each CLIA-designated role, including carve-outs such
as blood gas analysis. At the end of each checklist are examples of personnel records that can be used
to determine qualifications and a section for notes. Next slide, please. Moving on to an example
of the general supervisor qualification checklist for laboratories performing high-complexity
testing, and Ms. Parks is reviewing the qualifications of Mr. Green to determine
suitability to serve as a general supervisor in a laboratory performing high-complexity testing.
Mr. Green has an associate's degree in medical laboratory technology and over three years
experience working in a CLIA-certified laboratory performing high-complexity testing as testing
personnel. As you can see, he would qualify under Pathway 4, which aligns to the CLIA regulations
at 42 CFR, Part 493.1461C2I&II. Next slide, please. As you can see, each checklist provides
all the pathways through which an individual can qualify for each CLIA-designated role.
At the end of each checklist are examples of personnel records that can be used to determine
qualifications and a section for notes. We encourage everyone to visit the LDU webpage
and download these checklists. Next slide, please. Another really exciting resource that is in
development as part of LDU is the CLIA Deficiency and Resource Tool, or CDART. CDART is designed
to help laboratory directors and other laboratory professionals search and access regulations
relevant to common CLIA deficiencies and the specifics of the CLIA standard in 42 CFR,
Part 493, Laboratory Requirements. This exclusive search tool includes a dedicated
homepage within LDU, and users can enter deficiency tags or D-tags or familiar search terms
to help them find and download training, requirements, regulations, and more. Next
slide, please. CDART will serve as a resource for laboratory directors and clinical laboratory
personnel by providing recommended training that relates to specific CLIA D-tags and is aligned
with the CLIA regulations. When you select one or more D-tags, a list of available e-learnings,
job aids, and virtual reality scenarios is presented, along with a reference to the
appropriate Code of Federal Register details and interpretive guidelines for each D-tag.
Users will be able to download the results as recommended training. Next slide, please.
For example, if you were to search on D-5209, CDART will provide the CFR citation,
the CLIA interpretive guidelines, and the LDU training resources currently available.
We are currently continually expanding the resources available in CDART. If your search
does not return any results, it may be because the corresponding learning pathways and materials
are still in development. We anticipate the full list of relevant D-tags will be added to the
CDART tool by the end of September 2026. Next slide, please. We will continue to build out
LDU courses to focus on seven core learning topics in LDU, ranging from foundational CLIA
concepts to quality systems, proficiency testing, and a final capstone that applies
learning to real-world scenarios. The seven LDU learning topics are Introduction to Laboratory
Director University, Laboratory Director Responsibilities, Personnel Responsibilities,
the Survey Process, Quality Systems for Laboratories, Participation in Proficiency Testing,
and an LDU capstone which applies LDU concepts to real-life scenarios. Next slide, please.
So, for our courses under development, we have a few we can share today. In topic two,
we will cover Introduction to Laboratory Director Responsibilities
and the Purpose of the CLIA Survey. And in topic three, we will cover CLIA personnel
qualifications and responsibilities for cytology testing and a delegating responsibilities
practice example. Next slide, please. Thank you all so much for joining today.
We're excited to see what LDU can do for you and your laboratory. And next slide, please.
So, today we will only address the questions that pertain to the events topics. For all other
inquiries, please contact CMS Laboratory Excellence at labexcellence at cms.hhs.gov.
Thank you so much. Thank you. Like Cheryl said, we will take a few minutes to answer as many
questions as possible. If we do not get to answer your question today, we'll do our best to respond
via email. And if you have questions after today's webinar, please feel free to email us
at onelabinbox at onelabatcdc.gov. Or you can contact labexcellence at cmshhs.gov
for any CLIA-related questions. Okay, let's see what we have.
So, someone wants to know, can one person serve as the technical supervisor,
the clinical consultant, or the general supervisor? So, yeah, the short answer is yes.
There are actually laboratories out there where the laboratory director
is the laboratory director, the clinical consultant. They basically fulfill all the
roles in that laboratory. And so, as long as the individual is qualified for each role
that they have been delegated, then yes, they may serve in multiple roles. Great question. Thank you.
This is a pretty good one. So, someone wants to know, if a lab, they perform both moderate and
high complexity tests, which personnel organizational charge roles should they follow if they do both?
So, it depends on what responsibilities have been delegated to what individuals. So, if you're
talking about a typical hospital lab, which might have sections that only perform moderate
complexity testing, like say you have your urinalysis section, and that's all you do in there
is urine dips and micros, then those personnel only have to be qualified for moderate complexity.
There will have to be a technical consultant, however, who oversees the moderate complexity
testing. And then for the sections that perform both moderate and high complexity testing,
the individuals will have to be qualified to the highest level of testing that they perform.
So, if someone is performing both moderate and high, they will have to be qualified
to perform high complexity testing. And again, the laboratory will have to have
all of the CLIA required positions. So, if you're not performing cytology,
obviously, you don't have to have the cytology positions. But if you're performing moderate and
high, the laboratory will have to have one lab director, as many clinical consultants as they
prefer, you know, depending on the size of the lab. You might want more big hospitals would have
a lot of clinical consultants, small places, the lab director may be the person filling both roles.
And then you would have to have sufficient technical supervisors qualified for the
specialties or subspecialties that the laboratory performs, general supervisors,
technical consultants, and then your testing personnel. Again, great question. Thank you so
much for that question. And I think this will probably be
help them answer that as well. Could you give the practical difference between a moderate
and high complexity testing? So, the complexity of a test is assigned by the FDA.
When a laboratory, I'm sorry, when a test manufacturer develops a new test and submits
it to the FDA for approval or slash categorization, the FDA has a set of criteria that they use to
determine whether the test is moderate or high complexity. And there is the test complexity
database at FDA.gov that you can look up a specific test, you know, ABC monospot
on the FDA database to determine what complexity that manufacturer's test system is.
If a test is not categorized or approved by the FDA, it defaults to high complexity.
So, thank you for that. Yeah.
Well, we have time for one more question. Which level of complexity does the bachelor's
equivalent, I think equivalent, qualify for with a bachelor's level?
If someone is a clinical laboratory scientist or a BSMT, then they would qualify for high
complexity testing as well as moderate complexity testing. I hope that answers,
that's kind of a broad question. I hope that answers your question. I will say that I strongly
encourage everyone to go to the checklists that are on the OneLab website where you signed up
for this on the LGU webpage. I strongly encourage everyone, the checklists are there to help guide
you through a specific individual's education and training to determine what CLIA roles they
are qualified to fulfill. So, I strongly encourage you to use those checklists. They should help you.
And I believe that the link to that has been dropped in the chat.
Excellent. Thank you.
You're welcome. So, I say thank you again, Cheryl, for joining us. And I look forward
to you joining us again to give us more updates with LGU.
All right. Thank you, everyone. We're excited to provide these resources. Thank you all.
We are offering, next slide, please. We are offering one PACE credit for today's webinar.
The PACE certificates are immediately available on OneLab Reach in your MyLearner Hub for easy
access to receive PACE credit. After participating in today's session, just log into your OneLab
Reach account, visit the link in the chat, and use the passcode to complete the evaluation within two
weeks. Remember, you must be logged into your OneLab Reach account to access the evaluation.
You will also receive an email containing these instructions
if you miss the link and the passcode after the webinar today.
Next slide, please. As a reminder, the slides and audio recording of this event will be posted to
our website within two weeks of today. Again, within two weeks of today, it will be posted,
both the audio as well as the slides. And next slide, please.
Lastly, we encourage everyone to go back. I realize that is the last slide. We encourage
everyone to utilize the OneLab inbox to share your training needs and any feedback on OneLab.
With us, we actually use your input to select event topics, better understand the community
needs. And the OneLab email address is posted in the chat for easy access. And again, we thank
you for joining today's webinar. And if you have any questions about CLIA-related questions after
today, feel free to email them at labexcellence at cmshhs.gov. Again, that's labexcellence at
cms.hhs.gov. And if you have any OneLab questions, please feel free to email them at
OneLab at cdc.gov. And thank you again, and have a great rest of your day.
